Market Insights Health OTC Pharmaceuticals

Eye Care - Southern Asia

Southern Asia

In 2024, the revenue in the Eye Care market market in Southern Asia amounts to US$211.40m.
It is projected to experience an annual growth rate of 5.19% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in the market, reaching US$1,256.00m in 2024.
In terms of per person revenues, in Southern Asia generates US$0.11 in 2024.
In Southern Asia's eye care market, India is witnessing a rise in demand for herbal and Ayurvedic remedies.

Key regions: Australia, Japan, Brazil, United States, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Eye Care market in Southern Asia is experiencing significant growth and development due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Eye Care market in Southern Asia are shifting towards a greater emphasis on preventive eye care and a desire for high-quality products and services. Customers are becoming more aware of the importance of regular eye check-ups and are seeking out eye care professionals for comprehensive eye examinations. This preference for preventive care is driving the demand for eyeglasses, contact lenses, and other vision correction products. Additionally, customers are increasingly looking for innovative and technologically advanced solutions to address their eye health needs.Trends in the market indicate a growing demand for specialized eye care services such as refractive surgery and laser eye treatments. As disposable incomes rise in Southern Asia, more individuals are willing to invest in these procedures to correct vision problems and reduce their dependence on corrective eyewear. Furthermore, advancements in technology have made these procedures safer, more precise, and more accessible, contributing to their popularity among customers.Local special circumstances in Southern Asia, such as a large population and a high prevalence of vision problems, are also driving the growth of the Eye Care market. The region is home to a significant number of people with refractive errors, cataracts, and other eye conditions, creating a substantial customer base for eye care products and services. Additionally, the increasing urbanization and digitalization in Southern Asia have led to a rise in screen time and exposure to blue light, resulting in a higher incidence of digital eye strain and other vision-related issues.Underlying macroeconomic factors are playing a crucial role in the development of the Eye Care market in Southern Asia. The region's strong economic growth and rising disposable incomes have enabled more individuals to afford eye care products and services. Moreover, increasing healthcare expenditure and improved healthcare infrastructure are making eye care more accessible to a larger population. These factors, coupled with a growing awareness of eye health and the availability of a wide range of eye care solutions, are contributing to the expansion of the Eye Care market in Southern Asia.Overall, the Eye Care market in Southern Asia is witnessing significant growth and development driven by changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As the market continues to evolve, it presents opportunities for both local and international eye care providers to cater to the increasing demand for high-quality eye care products and services in the region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.